Flex Pharma (FLKS) Now Covered by Ladenburg Thalmann Financial Services

Ladenburg Thalmann Financial Services assumed coverage on shares of Flex Pharma (NASDAQ:FLKS) in a report published on Thursday, MarketBeat.com reports. The firm issued a buy rating and a $12.00 price target on the biotechnology company’s stock.

Several other equities research analysts have also weighed in on FLKS. Zacks Investment Research upgraded Flex Pharma from a hold rating to a buy rating and set a $3.75 price target on the stock in a research report on Tuesday, October 3rd. Cantor Fitzgerald restated a hold rating and set a $10.00 price target on shares of Flex Pharma in a research report on Monday, November 6th. Finally, Roth Capital restated a buy rating and set a $12.00 price target on shares of Flex Pharma in a research report on Wednesday, January 3rd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of Buy and a consensus target price of $9.79.

Flex Pharma (NASDAQ:FLKS) traded down $0.02 during midday trading on Thursday, hitting $4.37. The company had a trading volume of 9,751 shares, compared to its average volume of 82,447. Flex Pharma has a one year low of $2.68 and a one year high of $5.93. The company has a market capitalization of $72.25, a price-to-earnings ratio of -2.17 and a beta of 3.54.

Flex Pharma (NASDAQ:FLKS) last released its quarterly earnings results on Monday, November 6th. The biotechnology company reported ($0.54) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.60) by $0.06. Flex Pharma had a negative return on equity of 71.39% and a negative net margin of 2,655.19%. The company had revenue of $0.41 million for the quarter, compared to analyst estimates of $0.47 million. equities analysts expect that Flex Pharma will post -2.39 EPS for the current fiscal year.

An institutional investor recently raised its position in Flex Pharma stock. Ameriprise Financial Inc. grew its stake in Flex Pharma Inc (NASDAQ:FLKS) by 69.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 654,825 shares of the biotechnology company’s stock after acquiring an additional 268,505 shares during the quarter. Ameriprise Financial Inc. owned 3.82% of Flex Pharma worth $2,520,000 at the end of the most recent quarter. 27.26% of the stock is owned by institutional investors.

WARNING: This story was published by BBNS and is owned by of BBNS. If you are reading this story on another publication, it was stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this story can be read at https://baseballnewssource.com/markets/flex-pharma-flks-now-covered-by-ladenburg-thalmann-financial-services/1869186.html.

Flex Pharma Company Profile

Flex Pharma, Inc is a biotechnology company. The Company develops treatments for nocturnal leg cramps, muscle cramps and spasms associated with severe neuromuscular conditions, and exercise associated muscle cramps (EAMCs). The Company’s product candidates activate certain receptors in primary sensory neurons, which then act through neuronal circuits to reduce the repetitive firing, or hyperexcitability, of alpha-motor neurons in the spinal cord, thereby preventing or reducing the frequency and intensity of muscle cramps and spasms.

Analyst Recommendations for Flex Pharma (NASDAQ:FLKS)

Receive News & Ratings for Flex Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flex Pharma and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish
Mother of Pittsburgh Pirates Player Elias Diaz Has Been Kidnapped
Mother of Pittsburgh Pirates Player Elias Diaz Has Been Kidnapped
Giants Will Retire No. 25 of Barry Bonds in August
Giants Will Retire No. 25 of Barry Bonds in August
Mookie Betts Awarded Arbitration of $10.5 Million
Mookie Betts Awarded Arbitration of $10.5 Million


Leave a Reply

 
© 2006-2018 BBNS.